Neurocognitive Deficit Clinical Trial
— MMS-R-epOfficial title:
Concordance Between Mini-Mental Stats Examination (MMSE) and an Adapted Version of the MMSE in Reunion Island Population (MMS-Run) : Preliminary Study
NCT number | NCT05858489 |
Other study ID # | 2022/CHU/30 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | April 14, 2023 |
Est. completion date | June 2024 |
Illeteracy concerns more than 38% of Réunion Island's people older than 65 years old, which makes it an important risk factor for dementia and a limit to neurocognitive test's administration. The MMSRun is a Mini Mental State Examination's version adapted to illeteracy and Réunionese culture, inspired by Hindi Mental State Examination's work. It allows a way better participation during neurocognitive evaluation, but it has never been validated. This study is a peliminary study to a validation, where the concordance between scores obtained from MMSRun and from the consensual version of Mini Mental State Examination proposed by GRECO (Groupe de Réflexion sur les Evaluations Cognitives) - the only french version validated - on a hospitalized and eldery population will be analyzed.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | June 2024 |
Est. primary completion date | April 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility | Inclusion Criteria: - Patient who needs a cognitive evaluation by MMSe/MMS-RUN during usual medical care - Patient born and living in RĂ©union Island - Patient hospitalized in geriatrics department or in the departement of physical medecine and rehabilitation - Patient who agrees to participate in the study and who does not oppose to the use of his data Exclusion Criteria: - Patient with hearing and visual disorder that can interfere in cognitive test administration - Patient with altered state of consciousness (Glasgow score different of 15) - Patient diagnosed or having symtoms compatible with a psychiatric pathology with psychosis (altered perception of reality) - Patient with a current and severe addiction to Alcohol or any other drug (smoking excluded) - Patient deprived of liberty by judicial or administrative decision and patient under curatorship or guardianship |
Country | Name | City | State |
---|---|---|---|
Réunion | CHU de La Réunion | Saint-Denis |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de la Réunion |
Réunion,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Total scoring of MMSE | 30 questions, good response to a question = 1, bad response to a question = 0, global scoring between 0 and 30,
Pathological threshold according to the socio-cultural level : without diploma : total score <22 secondary education without the 3rd class : total score <23 secondary education from 3rd class to the senior year class (without bachelor degree) higher education : total score <26 |
Day 0 | |
Primary | Total scoring of MMS-RUN | 30 questions, good response to a question = 1, bad response to a question = 0, total score between 0 and 30,
Pathological threshold according to the socio-cultural level : without diploma : total score <22 secondary education without the 3rd class : total score <23 secondary education from 3rd class to the senior year class (without bachelor degree) higher education : total score <26 |
Day 1 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04697147 -
Zika and Neurodevelopment Among Infants in Grenada
|
N/A | |
Recruiting |
NCT04891471 -
WHOle Brain Irradiation or STEreotactic Radiosurgery for Five or More Brain Metastases (WHOBI-STER)
|
N/A | |
Recruiting |
NCT05497427 -
Normative Database and Test-Retest Reliability for BrainCheck Assessments
|
||
Completed |
NCT05377008 -
Intervention Effectiveness on the Neurocognitive Functioning of Children and Adolescents With Neurofibromatosis Type 1
|
N/A | |
Recruiting |
NCT04073966 -
MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
|
||
Withdrawn |
NCT04807478 -
Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)
|